Open access
2,207
Views
2
CrossRef citations to date
0
Altmetric
Report
NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies
Corinna Laua Research Laboratory, Nordland Hospital Trust, Bodø, NorwayCorrespondence[email protected]
https://orcid.org/0000-0003-1750-8065View further author information
Martin Berner McAdamb Department of Immunology, Oslo University Hospital-Rikshospitalet, and Centre for Immune Regulation, Oslo, Norway
https://orcid.org/0000-0001-9385-6964View further author information
Grethe Bergsetha Research Laboratory, Nordland Hospital Trust, Bodø, NorwayView further author information
, Algirdas Grevysb Department of Immunology, Oslo University Hospital-Rikshospitalet, and Centre for Immune Regulation, Oslo, Norway;c Centre for Immune Regulation and Department of Biosciences, University of Oslo, Oslo, NorwayView further author information
, Jack Ansgar Bruund Department of Medical Biology, Proteomics Platform, University of Tromsø, Tromsø, Norway
https://orcid.org/0000-0003-0614-2790View further author information
Judith Krey Ludviksena Research Laboratory, Nordland Hospital Trust, Bodø, NorwayView further author information
, Hilde Furea Research Laboratory, Nordland Hospital Trust, Bodø, Norway
https://orcid.org/0000-0002-3634-0969View further author information
Terje Espevike Centre of Molecular Inflammation Research, and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
https://orcid.org/0000-0003-0354-5068View further author information
Anders Moenf Department of Biosciences, Proteomics core facility, University of Oslo, Oslo, Norway
https://orcid.org/0000-0002-6936-0747View further author information
Jan Terje Andersenb Department of Immunology, Oslo University Hospital-Rikshospitalet, and Centre for Immune Regulation, Oslo, Norway;g Department of Pharmacology, Institute of Clinical Medicine, Oslo University Hospital and University of Oslo, Oslo, Norway
https://orcid.org/0000-0003-1710-1628View further author information
Tom Eirik Mollnesa Research Laboratory, Nordland Hospital Trust, Bodø, Norway;e Centre of Molecular Inflammation Research, and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;h Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway;i Faculty of Health Sciences and K. G. Jebsen TREC, University of Tromsø, Tromsø, Norway
https://orcid.org/0000-0002-5785-802XView further author information
Article: 1686319
|
Received 28 Aug 2019, Accepted 25 Oct 2019, Published online: 27 Nov 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.